Evidence map›Paper›PMID 19956753›Full record

ArticlePloS one2009

Influence of membrane CD25 stability on T lymphocyte activity: implications for immunoregulation.

Todd M Brusko, Clive H Wasserfall, Maigan A Hulme, Roniel Cabrera, Desmond Schatz, Mark A Atkinson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Todd M BruskoDepartment of Pathology, University of Florida, Gainesville, Florida, United States of America.
Clive H Wasserfall
Maigan A Hulme
Roniel Cabrera
Desmond Schatz
Mark A Atkinson
University of Florida · USUniversity of California, San Francisco · US

Funding

Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI MARK A. ATKINSON · 1997 to 2026
$32.9M
Mechanisms of Immunotherapy in IDD Prevention TrialsR01AI039250 · NIAID · UNIVERSITY OF FLORIDA · PI ATKINSON, MARK A · 1996 to 2004
$1.2M
NIAID NIH HHS AI39250NIAID NIH HHS AI42288NIAID NIH HHS P01 AI042288NIAID NIH HHS R01 AI039250
6 · The paper itself

Abstract

backgroundCD25, a component of the IL-2 receptor, is important in T cell proliferation, activation induced cell death, as well as the actions of both regulatory (Treg) and effector (Teff) T cells. Recent genome wide association studies have implicated the CD25 locus as an important region for genetic susceptibility to a number of autoimmune disorders, with serum levels of soluble CD25 receptor (sCD25) serving as a potential phenotypic marker for this association. However, the functional impact of CD25 cleavage, as well as the influence of sCD25 on immunoregulatory activities, remain largely unknown and form the basis of this effort. METHODOLOGY/PRINCIPAL

findingsThe generation of sCD25 by Treg (CD4(+)CD25(+)) and Teff (CD4(+)CD25(-)) cells was examined during in vitro suppression assays, efforts that demonstrated constitutive and stable surface CD25 expression on Treg throughout the period of in vitro assessment. In contrast, Teff cells increased CD25 expression during the process of in vitro suppression, with supernatant sCD25 levels correlating to the amount of cellular proliferation. Interestingly, under serum-free conditions, Tregs partially lost their characteristic anergic and suppressive properties. sCD25 supplementation at physiological concentrations to serum free in vitro suppression assays reduced Teff proliferation without specifically influencing suppression. Indeed, sCD25 production within these cultures correlated with cell death. CONCLUSIONS/SIGNIFICANCE: These results support the notion that sCD25 functions as both a surrogate marker of T cell activation as well as an indicator of subsequent cellular death. In addition, the role of CD25 in immunomodulation is likely dependent on the local inflammatory milieu, with molecules capable of modulating surface CD25 expression playing a key role in defining immune responsiveness.

Indexed as

AdultAutoimmune DiseasesCD4-Positive T-LymphocytesCell MembraneFemaleFlow CytometryHumansImmune SystemInterleukin-2Interleukin-2 Receptor alpha SubunitMaleMiddle AgedModels, BiologicalPhenotypeT-LymphocytesInterleukin-2Interleukin-2 Receptor alpha Subunit

Identifiers

PMID19956753
PMCPMC2775921
OpenAlexW1969596581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.